These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 17713926

  • 1. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
    Liu Y, Henry GD, Hegde RS, Baleja JD.
    Biochemistry; 2007 Sep 25; 46(38):10864-74. PubMed ID: 17713926
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of cottontail rabbit papillomavirus E6 oncoproteins with the hDlg/SAP97 tumor suppressor.
    Du M, Fan X, Hanada T, Gao H, Lutchman M, Brandsma JL, Chishti AH, Chen JJ.
    J Cell Biochem; 2005 Apr 01; 94(5):1038-45. PubMed ID: 15669058
    [Abstract] [Full Text] [Related]

  • 5. Acquisition of a phospho-acceptor site enhances HPV E6 PDZ-binding motif functional promiscuity.
    Sarabia-Vega V, Banks L.
    J Gen Virol; 2020 Sep 01; 101(9):954-962. PubMed ID: 30810519
    [Abstract] [Full Text] [Related]

  • 6. Crystal structure of the second PDZ domain of SAP97 in complex with a GluR-A C-terminal peptide.
    von Ossowski I, Oksanen E, von Ossowski L, Cai C, Sundberg M, Goldman A, Keinänen K.
    FEBS J; 2006 Nov 01; 273(22):5219-29. PubMed ID: 17069616
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peptide binding and NMR analysis of the interaction between SAP97 PDZ2 and GluR-A: potential involvement of a disulfide bond.
    von Ossowski L, Tossavainen H, von Ossowski I, Cai C, Aitio O, Fredriksson K, Permi P, Annila A, Keinänen K.
    Biochemistry; 2006 May 02; 45(17):5567-75. PubMed ID: 16634638
    [Abstract] [Full Text] [Related]

  • 13. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
    Ramirez J, Poirson J, Foltz C, Chebaro Y, Schrapp M, Meyer A, Bonetta A, Forster A, Jacob Y, Masson M, Deryckère F, Travé G.
    Angew Chem Int Ed Engl; 2015 Jun 26; 54(27):7958-62. PubMed ID: 26014966
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structural and functional characterization of the PDZ domain of the human phosphatase PTPN3 and its interaction with the human papillomavirus E6 oncoprotein.
    Genera M, Samson D, Raynal B, Haouz A, Baron B, Simenel C, Guerois R, Wolff N, Caillet-Saguy C.
    Sci Rep; 2019 May 15; 9(1):7438. PubMed ID: 31092861
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization.
    Webb Strickland S, Brimer N, Lyons C, Vande Pol SB.
    Virology; 2018 Mar 15; 516():127-138. PubMed ID: 29346075
    [Abstract] [Full Text] [Related]

  • 18. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J, Banks L.
    J Virol; 2017 Nov 15; 91(22):. PubMed ID: 28835500
    [Abstract] [Full Text] [Related]

  • 19. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
    Matsumoto Y, Nakagawa S, Yano T, Takizawa S, Nagasaka K, Nakagawa K, Minaguchi T, Wada O, Ooishi H, Matsumoto K, Yasugi T, Kanda T, Huibregtse JM, Taketani Y.
    J Med Virol; 2006 Apr 15; 78(4):501-7. PubMed ID: 16482544
    [Abstract] [Full Text] [Related]

  • 20. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.
    Nakagawa S, Huibregtse JM.
    Mol Cell Biol; 2000 Nov 15; 20(21):8244-53. PubMed ID: 11027293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.